2024: WHAT'S ON THE HORIZON? REFLECTIONS, PROJECTIONS,
AND EARNEST HOPES
Emerging from a tough few years, the biopharma industry has recently seen sizeable licensing deals, meaningful M&As, and creative financing solutions to support innovation. Sentiment at JPM and Biotech Showcase was generally upbeat, as company officials prepared to meet numerous headwinds with resilience and optimism. Panelists will discuss the investment and dealmaking climate, challenges facing the industry, ways to overcome the concerns, and the most efficient, productive measures drug developers can take to move confidently into the future.
Date: Wednesday, February 28th, 2024
Time: 11:00AM-12:15PM (ET), including Q&A
MODERATOR:
Karen Casey, Managing Editor, BioWorld
SPEAKERS:
Rachelle Jacques, President & CEO, Akari Therapeutics
David Jenkins, Vice President, Head of Research & External Innovation, Ipsen
Tim Opler, Managing Director, Global Healthcare Group, Stifel
Peter Rubin, Executive Director, No Patient Left Behind (NPLB)
